Short Report:: Persistence of tumor necrosis factor-α in situ after lesion healing in mucosal leishmaniasis

被引:20
作者
Amato, VS
Andrade, HF
Neto, VA
Duarte, MIS
机构
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, BR-01441000 Sao Paulo, Brazil
[2] Inst Trop Med, BR-05403000 Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Sch Med, Lab Discipline Pathol Transmissable dis, BR-01246000 Sao Paulo, SP, Brazil
关键词
D O I
10.4269/ajtmh.2003.68.527
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Mucosal leishmaniasis (ML) is a disease characterized by intense activation of inflammatory cells and extensive tissue destruction. Among the cytokines involved in the immune response to ML, tumor necrosis factor-alpha (TNF-alpha) has attracted strong interest because of its roles in the modulation of the immune response. We studied 20 patients with ML who provided biopsy specimens before treatment and after lesion healing obtained by specific therapy. The biopsy specimens were subjected to immunohistochemical analysis for in situ quantification of cellular and extracellular TNF-alpha. The amount of TNF-alpha was significantly lower in the healed lesions compared with pretreatment biopsy specimens, although TNF-alpha persisted at the tissue level even after lesion healing. This relevant finding demonstrates for the first time an in situ tissue reduction of TNF-alpha after treatment and shows persistence of TNF-alpha in healed lesions may be related to the maintenance of an immunopathologic background for relapses observed in ML.
引用
收藏
页码:527 / 528
页数:2
相关论文
共 15 条
[1]  
Amato V S, 1995, Rev Soc Bras Med Trop, V28, P129
[2]   TUMOR-NECROSIS-FACTOR PRODUCTION IN PATIENTS WITH LEPROSY [J].
BARNES, PF ;
CHATTERJEE, D ;
BRENNAN, PJ ;
REA, TH ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1992, 60 (04) :1441-1446
[3]   THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :625-655
[4]   POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS [J].
CABRERA, M ;
SHAW, MA ;
SHARPLES, C ;
WILLIAMS, H ;
CASTES, M ;
CONVIT, J ;
BLACKWELL, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1259-1264
[5]  
CARVALHO EM, 1985, J IMMUNOL, V135, P4144
[6]  
Castes M, 1993, Biol Res, V26, P233
[7]  
D'Oliveira Junior Argemiro, 2002, Rev. Soc. Bras. Med. Trop., V35, P7, DOI 10.1590/S0037-86822002000100002
[8]   Tumor necrosis factor-alpha in human American tegumentary leishmaniasis [J].
DaCruz, AM ;
deOliveira, MP ;
DeLuca, PM ;
Mendonca, SCF ;
Coutinho, SG .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1996, 91 (02) :225-229
[9]   A REVIEW OF THE GEOGRAPHIC-DISTRIBUTION AND EPIDEMIOLOGY OF LEISHMANIASIS IN THE NEW-WORLD [J].
GRIMALDI, G ;
TESH, RB ;
MCMAHONPRATT, D .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 41 (06) :687-725
[10]   Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony [J].
Lessa, HA ;
Machado, P ;
Lima, F ;
Cruz, AA ;
Bacellar, O ;
Guerreiro, J ;
Carvalho, EM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 65 (02) :87-89